Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting of postneoadjuvant systemic therapy breast cancer specimens|
|Full bibliographic reference||Provenzano E, Bossuyt V, Viale G, Cameron D, Badve S, Denkert C, MacGrogan G, Penault-Llorca F, Boughey J, Curigliano G, Dixon JM, Esserman L, Fastner G, Kuehn T, Peintinger F, von Minckwitz G, White J, Yang W, Symmans WF; Residual Disease Characterization Working Group of the Breast International Group-North American Breast Cancer Group Collaboration. Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group. Mod Pathol. 2015;28(9):1185-1201.|
|Study design||Clinical trials, Experimental studies|
|Clinical area||Oncology, Pathology|
|Applies to the whole report or to individual sections of the report?||Intervention (exposure), Procedure/Method, Study characteristics (participants etc.), Terminology/definitions|
|Record last updated on||October 21, 2016|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.